ScinoPharm Taiwan to invest in U.S. Tanvex Biologics
ScinoPharm, a Taiwan-based API maker invested Tanvex Biologics, expanding presence in US biosimilars contracting market.
Archives for August 31, 2010
TiGenix to spin-out drug discovery activities as Arcarios
TiGenix to spin-out its discovery and development business as new small-molecule focused industry-academia consortium Arcarios.
RecipharmCobra gets patents for yield-boosting plasmid tech
RecipharmCobra Biologics has received US and EU patent protection for an antibiotic resistance gene-free plasmid maintenance technology it claims can boost biomanufacturing yields.
Top strategies for recruiting and retaining trial participants
Retention strategies, trial site evaluations and dedicated budgets should be used to recruit patients to, and keep them in, clinical trials, according to research.
Industry view
Regulatory expert insight: Regulatory information management
Tracking “non-content” metadata is an important part of any pharmaceutical submission, yet many drugmakers fail to take an integrated approach to the task according to regulatory expert Kate Wilber.
NanGenex adds bench-top, pilot nano API production tech
NanGenex is introducing GMP bench-top and pilot plant reactors to scale-up its process for the continuous production of nanostructured active ingredients.
ImmunoSolv & GBC merge; plan contract services growth
ImmunoSolv is merging with Grampian BioConsultants (GBC) and plans to accelerate development of the contract research business.